Evommune, Inc. (EVMN)

12.04 +0.04 (+0.33%) USD  |  NYSE  |  Sep 04, 10:28
More

Evommune Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for EVMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2023. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
Date Value
December 31, 2023 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
MapLight Therapeutics, Inc. --
Mineralys Therapeutics, Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. --
Sangamo Therapeutics, Inc. Upgrade